Every risk function you use. None of the wholesale-desk weight.
Traditional ETRMs were built for wholesale trading floors, and they are priced and staffed like it. Risk360 gives retail suppliers the risk functions they actually use — positions, forecasting, VaR, scheduling, nominations, settlements — with a desk to run it, and it can sit on top of an ETRM you already own.
How Risk360 compares
Risk360 against the enterprise ETRMs, the modern CTRMs, and the ISO settlement specialists.
| Capability | Risk360Us | ION | Molecule | Amphora | PCI |
|---|---|---|---|---|---|
| Position and hedge management | |||||
| Real-time P&L attribution | |||||
| VaR modeling | |||||
| Load forecasting built in | |||||
| Electric scheduling and gas nominations | |||||
| Settlement reconciliation | |||||
| Retail supplier fit (not wholesale cost) | |||||
| Managed services option | |||||
| Sits on top of your existing ETRM via API | |||||
| Onboarding in weeks, not quarters |
Comparison reflects publicly available positioning as of August 2026. ION, Molecule, and Amphora serve trading desks broadly; the honest read is below.
Where each option actually wins
No vendor is best at everything. Here is the honest read, so you can pick on fit, not noise.
Risk360 wins when
You are a retail supplier who wants risk plus operations plus a desk without wholesale-ETRM cost and complexity, and you want to be live in weeks. It can also layer on top of an ETRM you already run.
ION wins when
You are a large wholesale trading operation that needs the enterprise standard and has the budget and team to run it.
Molecule wins when
You are a trading shop that wants a clean, modern SaaS CTRM focused on trade capture, position, and P&L.
Amphora wins when
You want an established CTRM for commodity trading and have your own operations and forecasting elsewhere.
PCI wins when
You are generation or utility heavy and need deep ISO settlements and market participation as the center of gravity.